Delivery Order SPE2DB22D1017-SPE2DB24FF2TR

Award Date 2/12/24
Potential Completion Date 2/13/24
Potential Value $3.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Advair HFA 230-21 mcg inhalers to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The 12-month, firm fixed price contract, valued at $5,886.79, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA). The $9,604.00 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has a completion date of May 7, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...
This federal contract award is for the delivery of Advair HFA 115-21 MCG inhalers to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $7,845.98, is a firm-fixed-price delivery order with a final completion date of February 6, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Advair HFA 45-21 MCG inhalers to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 7, 2024, with a completion date of February 8, 2024. The contract has a ceiling value of $1,335.71 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which...
The federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA). The Firm Fixed Price delivery order, valued at $4,701.81, has an ultimate completion date of March 1, 2024. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 115-21 mcg inhalers. The $25,074.96 firm fixed-price delivery order contract has a completion date of May 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., has a ceiling value of $20,360.53 and runs through March 7, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
The federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers, with a ceiling value of $1,573.29. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. This contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation. The period of performance runs from the award...
This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler, 12GM to the Defense Logistics Agency (DLA). The contract, valued at $1,561.98, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order with a firm fixed price and a completion date of January 30, 2024. The contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., as a firm fixed-price delivery order. The contract has a ceiling value of $3,853.72 and an ultimate completion date of February 27, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF2TR
    Delivery Order

This federal contract award is for the delivery of Advair HFA 115-21 MCG inhalers, valued at $3,136.93, to the Defense Logistics Agency (DLA) from Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order contract with a firm fixed price, with a completion date of February 13, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 5/14/25, 9:47 AM